We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+11.97%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$126B
AUM Growth
+$5.23B
(+4.3%)
Cap. Flow
-$4.63B
Cap. Flow
% of AUM
-3.67%
Top 10 Holdings %
Top 10 Hldgs %
31.85%
Holding
346
New
11
Increased
124
Reduced
177
Closed
13
Avg Time Held
6.9
years
Top 10 Avg Time Held
4.3
years
Top 20 Avg Time Held
5.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charles Schwab
SCHW
|
+$421M |
| 2 |
Amazon
AMZN
|
+$401M |
| 3 |
ConocoPhillips
COP
|
+$282M |
| 4 |
Danaher
DHR
|
+$217M |
| 5 |
Flutter Entertainment
FLUT
|
+$188M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.04B |
| 2 |
Sony
SONY
|
+$581M |
| 3 |
Micron Technology
MU
|
+$543M |
| 4 |
Amgen
AMGN
|
+$498M |
| 5 |
Adobe
ADBE
|
+$487M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.56% |
| 2 | Healthcare | 25.76% |
| 3 | Industrials | 11.23% |
| 4 | Consumer Discretionary | 10.57% |
| 5 | Financials | 9.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
301
Ingevity
NGVT
$2.43B
| $2.97M | ﹤0.01% |
69,000
| – | – |
2017 Q4
30 quarters
|
|
302
Coca-Cola
KO
$396B
| $2.49M | ﹤0.01% |
+35,200
| New | +$2.51M |
2025 Q2
0 quarters
|
|
303
Wolfspeed
WOLF
$1.37B
| $2.42M | ﹤0.01% |
6,075,113
-590,157
| -9% | -$1.35M |
2013 Q2
48 quarters
|
|
304
Nurix Therapeutics
NRIX
$2.73B
| $2.39M | ﹤0.01% |
210,000
-22,000
| -9% | -$238K |
2024 Q1
5 quarters
|
|
305
CAVA Group
CAVA
$6.47B
| $2.22M | ﹤0.01% |
+26,300
| New | +$2.24M |
2025 Q2
0 quarters
|
|
306
Allegiant Air
ALGT
$1.92B
| $2.2M | ﹤0.01% |
40,050
| – | – |
2013 Q2
48 quarters
|
|
307
Globus Medical
GMED
$10.6B
| $2.1M | ﹤0.01% |
35,625
-2,900
| -8% | -$187K |
2023 Q3
7 quarters
|
|
308
Cerus
CERS
$455M
| $1.85M | ﹤0.01% |
1,315,400
-203,800
| -13% | -$272K |
2015 Q1
41 quarters
|
|
309
Arista Networks
ANET
$234B
| $1.72M | ﹤0.01% |
16,800
| – | – |
2014 Q2
44 quarters
|
|
310
Cboe Global Markets
CBOE
$32.2B
| $1.7M | ﹤0.01% |
7,300
-1,400
| -16% | -$312K |
2018 Q3
27 quarters
|
|
311
Greif Class B
GEF.B
$4.18B
| $1.59M | ﹤0.01% |
23,000
| – | – |
2013 Q2
48 quarters
|
|
312
Marqeta
MQ
$1.98B
| $1.57M | ﹤0.01% |
67,150
-10,125
| -13% | -$192K |
2021 Q3
15 quarters
|
|
313
Duolingo
DUOL
$6.97B
| $1.5M | ﹤0.01% |
3,650
-1,700
| -32% | -$746K |
2023 Q1
9 quarters
|
|
314
Ambarella
AMBA
$2.8B
| $1.45M | ﹤0.01% |
21,900
-3,400
| -13% | -$180K |
2020 Q3
19 quarters
|
|
315
Zentalis Pharmaceuticals
ZNTL
$212M
| $1.19M | ﹤0.01% |
1,027,620
-237,000
| -19% | -$313K |
2020 Q2
20 quarters
|
|
316
Valvoline
VVV
$4.03B
| $1.05M | ﹤0.01% |
27,630
+500
| +2% | +$17.5K |
2025 Q1
1 quarter
|
|
317
DELISTED
Sun Country Airlines
SNCY
| $964K | ﹤0.01% |
82,015
-800
| -1% | -$8.79K |
2021 Q1
17 quarters
|
|
318
Fortinet
FTNT
$133B
| $740K | ﹤0.01% |
7,000
-62,450
| -90% | -$6.3M |
2023 Q1
9 quarters
|
|
319
DELISTED
Leslie's
LESL
| $551K | ﹤0.01% |
65,557
| – | – |
2021 Q4
14 quarters
|
|
320
Circle Internet Group
CRCL
$22.1B
| $489K | ﹤0.01% |
+2,700
| New | +$440K |
2025 Q2
0 quarters
|
|
321
Kyntra Bio
KYNB
$21.7M
| $475K | ﹤0.01% |
89,696
-59,937
| -40% | -$437K |
2019 Q4
22 quarters
|
|
322
Shutterstock
SSTK
$170M
| $386K | ﹤0.01% |
20,359
| – | – |
2023 Q2
8 quarters
|
|
323
GrowGeneration
GRWG
$87.8M
| $353K | ﹤0.01% |
377,300
-81,000
| -18% | -$86.4K |
2022 Q1
13 quarters
|
|
324
Standard BioTools
LAB
$258M
| $347K | ﹤0.01% |
288,774
-343,300
| -54% | -$381K |
2013 Q2
48 quarters
|
|
325
DELISTED
ZimVie
ZIMV
| $326K | ﹤0.01% |
34,840
| – | – |
2022 Q1
13 quarters
|
|
Similar funds
Primecap Management's Q2 2025 Portfolio in Review
As of Q2 2025, Primecap Management held 346 positions worth $126B, up 4.3% from $121B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Primecap Management withdrew a net $4.63B in Q2 2025, closing 13 positions and reducing 177 holdings. Its most notable exit was Discover Financial Services, an estimated $98.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Primecap Management opened a new position in Capital One worth $116M.
- Primecap Management's largest Q2 2025 buy was Capital One: 545,321 shares worth $116M.
- Primecap Management added most to Charles Schwab in Q2 2025, an estimated $421M increase.
- Primecap Management's biggest Q2 2025 reduction was Eli Lilly, cutting an estimated $2.04B.
- Primecap Management fully exited Discover Financial Services in Q2 2025, selling an estimated $98.1M.
- Primecap Management's ten largest holdings make up 32% of its $126B portfolio in Q2 2025.
- Primecap Management opened 11 new positions and closed 13 in Q2 2025.
- Primecap Management's portfolio value rose 4.3% quarter-over-quarter to $126B.
Based on Primecap Management's 13F filing for Q2 2025, filed 11 Aug 2025.